Results 51 to 60 of about 21,134 (213)

Microcore Skin Biopsies: A Novel, Micro‐Invasive Skin Biopsy Technique Yielding Full‐Thickness Histology

open access: yesSkin Research and Technology, Volume 32, Issue 7, July 2026.
ABSTRACT Background Punch biopsies are considered the primary technique to obtain full‐thickness skin specimens for dermatologic diagnoses. However, limitations include scarring, sampling error, poor margin identification, and post‐sampling deformations.
Rebecca Lapides   +9 more
wiley   +1 more source

Primary Cutaneous Adenoid Cystic Carcinoma (PCACC) of the Scalp: dermatosurgical approach with favourable outcome

open access: yesDermatology Reports, 2022
Although described as early as 1975 as a distinct, rare form of cancer with diverse localization, primary cutaneous adenoid cystic carcinoma (PCACC) remains a mystery and challenge for both clinicians and pathologists.
Georgi Tchernev   +4 more
doaj   +1 more source

Treatment of palpebral melanocytic nevi with a dual-wavelengths copper vapor laser

open access: yesVestnik Dermatologii i Venerologii, 2020
Acquired melanocytic nevi in aesthetically significant areas, especially palpebral nevi (PN), are becoming a frequent reason for patients to seek dermatologists.
I. V. Ponomarev   +3 more
doaj   +1 more source

False-positive iodine-131 whole body scan due to a benign dermal lesion; Intradermal nevus (131I uptake in a benign nevus)

open access: yes, 2013
Whole body radioiodine scanning (WBS), along with plasma thyroglobulin level, remains a reference method for detecting residual or metastatic differentiated thyroid cancer, however, false-positive WBS is not uncommon.
Kilinc, Sule   +8 more
core   +1 more source

Primary mucinous carcinoma of the skin

open access: yesClinical Case Reports, 2023
Key Clinical Message Mucinous carcinoma of the skin is clinically characterized by good mobility, slow growth, a macroscopically smooth surface, no easy contact bleeding, and no internal flow on color Doppler; it is thus difficult to distinguish from ...
Takayuki Yamada
doaj   +1 more source

The Impact of Next‐Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Deep Penetrating Melanocytic Neoplasms

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 3, Page 293-301, March 2026.
ABSTRACT Background Next‐generation sequencing (NGS) is becoming more commonly used for diagnosis in dermatopathology. It's critical to appraise its efficacy and limitations. Distinguishing benign deep penetrating nevi (DPN) from deep penetrating like‐melanoma (DPN‐M) is a challenging diagnostic scenario even for experienced dermatopathologists ...
Julia Edwin Jeyakumar   +37 more
wiley   +1 more source

Two cases of pigmented nevus of the palatal mucosa and review of Japanese literatures [PDF]

open access: yes, 1997
P(論文)Two cases of pigmented nevus of the palate are presented. The first case was an intradermal pigmented nevus in a 32-year-old male and the other a junctional pigmented nevus in a 49-year-old female.
金澤, 正昭   +7 more
core  

WHO classification of skin tumours: key updates in the fifth edition

open access: yesHistopathology, Volume 88, Issue 3, Page 555-568, February 2026.
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Gabrielle Goldman‐Lévy   +29 more
wiley   +1 more source

Agminated intradermal Spitz nevi arising on an unusual speckled lentiginous nevus with localized lentiginosis: a continuum?

open access: yes, 1997
We report an 18-year-old boy with a congenital pigmented lesion measuring 2 x 6 cm on his right thigh. About a third of the lesion was composed of numerous lentiginous macules superimposed on histologically normal and clinically nontan skin; in the ...
E. Inselvini   +3 more
core   +1 more source

Melanoma: Pathogenesis and Targeted Therapy

open access: yesMedComm, Volume 7, Issue 1, January 2026.
The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy